Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A story published by The Columbus Dispatch cited an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, titled “Cigna Dangles $500 to Persuade Patients to Switch Psoriasis Drugs,” indicated that as the first quarter of 2021 ended, patients choosing to keep using secukinumab may have been offered an inducement to switch to another biologic, ixekizumab.
A press release issued by Cano Health referenced a study published in the June 2021 issue of AJMC®, titled “Managed Care COVID-19 Outcomes in a Population Health Program.” The study found that COVID-19–specific mortality for Cano Health members was 60% lower compared with an age- and gender-matched mirror group of Florida residents.
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More
As CMS Embarks on “Rural Transformation,” a New Jersey Health System Weighs In
July 19th 2025CMS Administrator Mehmet Oz, MD, MBA, visited AtlantiCare leaders in Atlantic City, New Jersey, to discuss the need for legislative and regulatory reform, as well as the $50 billion Rural Transformation Program.
Read More